These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21358412)
1. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe. Morrison CS; Chen PL; Nankya I; Rinaldi A; Van Der Pol B; Ma YR; Chipato T; Mugerwa R; Dunbar M; Arts E; Salata RA J Acquir Immune Defic Syndr; 2011 Jun; 57(2):157-64. PubMed ID: 21358412 [TBL] [Abstract][Full Text] [Related]
2. Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe. Bengtson A; Kwok C; Salata RA; Byamugisha J; Chipato T; Rwambuya S; Moyo P; Morrison CS J Acquir Immune Defic Syndr; 2013 Aug; 63(4):506-13. PubMed ID: 23572011 [TBL] [Abstract][Full Text] [Related]
3. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples. Lutalo T; Musoke R; Kong X; Makumbi F; Serwadda D; Nalugoda F; Kigozi G; Sewankambo N; Sekasanvu J; Wawer M; Gray R AIDS; 2013 Oct; 27 Suppl 1():S27-34. PubMed ID: 24088681 [TBL] [Abstract][Full Text] [Related]
4. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness. Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261 [TBL] [Abstract][Full Text] [Related]
5. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression. Morrison CS; Hofmeyr GJ; Thomas KK; Rees H; Philip N; Palanee-Phillips T; Nanda K; Nair G; Onono M; Mastro TD; Lind M; Heffron R; Edward V; Deese J; Beksinska M; Beesham I; Stringer JSA; Baeten JM; Ahmed K; AIDS Res Hum Retroviruses; 2020 Aug; 36(8):632-640. PubMed ID: 32394723 [TBL] [Abstract][Full Text] [Related]
6. A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy. Morrison CS; Fichorova R; Chen PL; Kwok C; Deese J; Yamamoto H; Anderson S; Chipato T; Salata R; Doncel GF AIDS Res Hum Retroviruses; 2018 Oct; 34(10):889-899. PubMed ID: 30047279 [TBL] [Abstract][Full Text] [Related]
7. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. Balkus JE; Brown ER; Hillier SL; Coletti A; Ramjee G; Mgodi N; Makanani B; Reid C; Martinson F; Soto-Torres L; Abdool Karim SS; Chirenje ZM Contraception; 2016 Jan; 93(1):25-31. PubMed ID: 26519646 [TBL] [Abstract][Full Text] [Related]
8. Hormonal contraception and the risk of HIV acquisition. Morrison CS; Richardson BA; Mmiro F; Chipato T; Celentano DD; Luoto J; Mugerwa R; Padian N; Rugpao S; Brown JM; Cornelisse P; Salata RA; AIDS; 2007 Jan; 21(1):85-95. PubMed ID: 17148972 [TBL] [Abstract][Full Text] [Related]
9. Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand. Nanda K; Morrison CS; Kwok C; Byamugisha J; Jones L; Sriplienchan S; Magwali T Contraception; 2011 Jun; 83(6):542-8. PubMed ID: 21570552 [TBL] [Abstract][Full Text] [Related]
10. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Myer L; Denny L; Wright TC; Kuhn L Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547 [TBL] [Abstract][Full Text] [Related]
11. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda. Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162 [TBL] [Abstract][Full Text] [Related]
12. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women. Kiweewa FM; Brown E; Mishra A; Nair G; Palanee-Phillips T; Mgodi N; Nakabiito C; Chakhtoura N; Hillier SL; Baeten JM; J Int AIDS Soc; 2019 Feb; 22(2):e25257. PubMed ID: 30816632 [TBL] [Abstract][Full Text] [Related]
13. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women. Castilho JL; Jenkins CA; Shepherd BE; Bebawy SS; Turner M; Sterling TR; Melekhin VV J Womens Health (Larchmt); 2015 Jun; 24(6):481-8. PubMed ID: 25751720 [TBL] [Abstract][Full Text] [Related]
15. Hormonal contraception and the risk of HIV acquisition among women in South Africa. Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973 [TBL] [Abstract][Full Text] [Related]
16. Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial. Akello CA; Bunge KE; Nakabiito C; Mirembe BG; Fowler MG; Mishra A; Marrazzo J; Chirenje ZM; Celum C; Balkus JE J Womens Health (Larchmt); 2017 Jun; 26(6):670-676. PubMed ID: 28437215 [TBL] [Abstract][Full Text] [Related]
17. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception. Heffron R; Mugo N; Were E; Kiarie J; Bukusi EA; Mujugira A; Frenkel LM; Donnell D; Ronald A; Celum C; Baeten JM; AIDS; 2014 Nov; 28(18):2771-6. PubMed ID: 25493602 [TBL] [Abstract][Full Text] [Related]